Global Gout Medications Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Gout Medications Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Gout Medications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Gout Relief Drugs
  • 1.2.3 Gout Treatment Drugs
• 1.3 Market by Application
  • 1.3.1 Global Gout Medications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Primary Gout
  • 1.3.3 Secondary Gout
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Gout Medications Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Gout Medications Revenue by Region
  • 2.2.1 Global Gout Medications Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Gout Medications Revenue by Region (2019-2024)
  • 2.2.3 Global Gout Medications Revenue by Region (2025-2030)
  • 2.2.4 Global Gout Medications Revenue Market Share by Region (2019-2030)
• 2.3 Global Gout Medications Sales Estimates and Forecasts 2019-2030
• 2.4 Global Gout Medications Sales by Region
  • 2.4.1 Global Gout Medications Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Gout Medications Sales by Region (2019-2024)
  • 2.4.3 Global Gout Medications Sales by Region (2025-2030)
  • 2.4.4 Global Gout Medications Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Gout Medications Sales by Manufacturers
  • 3.1.1 Global Gout Medications Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Gout Medications Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gout Medications in 2023
• 3.2 Global Gout Medications Revenue by Manufacturers
  • 3.2.1 Global Gout Medications Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Gout Medications Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Gout Medications Revenue in 2023
• 3.3 Global Key Players of Gout Medications, Industry Ranking, 2021 VS 2022
• 3.4 Global Gout Medications Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Gout Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Gout Medications, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Gout Medications, Product Offered and Application
• 3.8 Global Key Manufacturers of Gout Medications, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Gout Medications Sales by Type
  • 4.1.1 Global Gout Medications Historical Sales by Type (2019-2024)
  • 4.1.2 Global Gout Medications Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Gout Medications Sales Market Share by Type (2019-2030)
• 4.2 Global Gout Medications Revenue by Type
  • 4.2.1 Global Gout Medications Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Gout Medications Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Gout Medications Revenue Market Share by Type (2019-2030)
• 4.3 Global Gout Medications Price by Type
  • 4.3.1 Global Gout Medications Price by Type (2019-2024)
  • 4.3.2 Global Gout Medications Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Gout Medications Sales by Application
  • 5.1.1 Global Gout Medications Historical Sales by Application (2019-2024)
  • 5.1.2 Global Gout Medications Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Gout Medications Sales Market Share by Application (2019-2030)
• 5.2 Global Gout Medications Revenue by Application
  • 5.2.1 Global Gout Medications Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Gout Medications Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Gout Medications Revenue Market Share by Application (2019-2030)
• 5.3 Global Gout Medications Price by Application
  • 5.3.1 Global Gout Medications Price by Application (2019-2024)
  • 5.3.2 Global Gout Medications Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Gout Medications Market Size by Type
  • 6.1.1 US & Canada Gout Medications Sales by Type (2019-2030)
  • 6.1.2 US & Canada Gout Medications Revenue by Type (2019-2030)
• 6.2 US & Canada Gout Medications Market Size by Application
  • 6.2.1 US & Canada Gout Medications Sales by Application (2019-2030)
  • 6.2.2 US & Canada Gout Medications Revenue by Application (2019-2030)
• 6.3 US & Canada Gout Medications Market Size by Country
  • 6.3.1 US & Canada Gout Medications Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Gout Medications Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Gout Medications Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Gout Medications Market Size by Type
  • 7.1.1 Europe Gout Medications Sales by Type (2019-2030)
  • 7.1.2 Europe Gout Medications Revenue by Type (2019-2030)
• 7.2 Europe Gout Medications Market Size by Application
  • 7.2.1 Europe Gout Medications Sales by Application (2019-2030)
  • 7.2.2 Europe Gout Medications Revenue by Application (2019-2030)
• 7.3 Europe Gout Medications Market Size by Country
  • 7.3.1 Europe Gout Medications Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Gout Medications Revenue by Country (2019-2030)
  • 7.3.3 Europe Gout Medications Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Gout Medications Market Size by Type
  • 8.1.1 China Gout Medications Sales by Type (2019-2030)
  • 8.1.2 China Gout Medications Revenue by Type (2019-2030)
• 8.2 China Gout Medications Market Size by Application
  • 8.2.1 China Gout Medications Sales by Application (2019-2030)
  • 8.2.2 China Gout Medications Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Gout Medications Market Size by Type
  • 9.1.1 Asia Gout Medications Sales by Type (2019-2030)
  • 9.1.2 Asia Gout Medications Revenue by Type (2019-2030)
• 9.2 Asia Gout Medications Market Size by Application
  • 9.2.1 Asia Gout Medications Sales by Application (2019-2030)
  • 9.2.2 Asia Gout Medications Revenue by Application (2019-2030)
• 9.3 Asia Gout Medications Market Size by Region
  • 9.3.1 Asia Gout Medications Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Gout Medications Revenue by Region (2019-2030)
  • 9.3.3 Asia Gout Medications Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Gout Medications Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Gout Medications Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Gout Medications Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Gout Medications Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Gout Medications Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Gout Medications Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Gout Medications Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Gout Medications Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Gout Medications Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Gout Medications Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 AstraZeneca
  • 11.1.1 AstraZeneca Company Information
  • 11.1.2 AstraZeneca Overview
  • 11.1.3 AstraZeneca Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 AstraZeneca Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 AstraZeneca Recent Developments
• 11.2 Merck
  • 11.2.1 Merck Company Information
  • 11.2.2 Merck Overview
  • 11.2.3 Merck Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Merck Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Merck Recent Developments
• 11.3 Hikma Pharmaceuticals plc
  • 11.3.1 Hikma Pharmaceuticals plc Company Information
  • 11.3.2 Hikma Pharmaceuticals plc Overview
  • 11.3.3 Hikma Pharmaceuticals plc Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Hikma Pharmaceuticals plc Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Hikma Pharmaceuticals plc Recent Developments
• 11.4 Takeda Pharmaceutical Company Limited
  • 11.4.1 Takeda Pharmaceutical Company Limited Company Information
  • 11.4.2 Takeda Pharmaceutical Company Limited Overview
  • 11.4.3 Takeda Pharmaceutical Company Limited Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Takeda Pharmaceutical Company Limited Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Takeda Pharmaceutical Company Limited Recent Developments
• 11.5 Sebelalreland
  • 11.5.1 Sebelalreland Company Information
  • 11.5.2 Sebelalreland Overview
  • 11.5.3 Sebelalreland Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Sebelalreland Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Sebelalreland Recent Developments
• 11.6 Teijin Pharma
  • 11.6.1 Teijin Pharma Company Information
  • 11.6.2 Teijin Pharma Overview
  • 11.6.3 Teijin Pharma Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Teijin Pharma Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Teijin Pharma Recent Developments
• 11.7 Sanofi
  • 11.7.1 Sanofi Company Information
  • 11.7.2 Sanofi Overview
  • 11.7.3 Sanofi Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Sanofi Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Sanofi Recent Developments
• 11.8 FUJI YAKUHIN
  • 11.8.1 FUJI YAKUHIN Company Information
  • 11.8.2 FUJI YAKUHIN Overview
  • 11.8.3 FUJI YAKUHIN Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 FUJI YAKUHIN Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 FUJI YAKUHIN Recent Developments
• 11.9 Savient Pharmaceuticals, Inc.
  • 11.9.1 Savient Pharmaceuticals, Inc. Company Information
  • 11.9.2 Savient Pharmaceuticals, Inc. Overview
  • 11.9.3 Savient Pharmaceuticals, Inc. Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Savient Pharmaceuticals, Inc. Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Savient Pharmaceuticals, Inc. Recent Developments
• 11.10 lroko Pharmaceuticals
  • 11.10.1 lroko Pharmaceuticals Company Information
  • 11.10.2 lroko Pharmaceuticals Overview
  • 11.10.3 lroko Pharmaceuticals Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 lroko Pharmaceuticals Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 lroko Pharmaceuticals Recent Developments
• 11.11 Novartis
  • 11.11.1 Novartis Company Information
  • 11.11.2 Novartis Overview
  • 11.11.3 Novartis Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Novartis Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Novartis Recent Developments
• 11.12 Astellas Pharma Hong Kong Co., Ltd
  • 11.12.1 Astellas Pharma Hong Kong Co., Ltd Company Information
  • 11.12.2 Astellas Pharma Hong Kong Co., Ltd Overview
  • 11.12.3 Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Astellas Pharma Hong Kong Co., Ltd Recent Developments
• 11.13 Hengrui Medicine
  • 11.13.1 Hengrui Medicine Company Information
  • 11.13.2 Hengrui Medicine Overview
  • 11.13.3 Hengrui Medicine Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Hengrui Medicine Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Hengrui Medicine Recent Developments
• 11.14 ApicHope
  • 11.14.1 ApicHope Company Information
  • 11.14.2 ApicHope Overview
  • 11.14.3 ApicHope Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 ApicHope Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 ApicHope Recent Developments
• 11.15 INVENTISBIO CO. LTD.
  • 11.15.1 INVENTISBIO CO. LTD. Company Information
  • 11.15.2 INVENTISBIO CO. LTD. Overview
  • 11.15.3 INVENTISBIO CO. LTD. Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 INVENTISBIO CO. LTD. Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 INVENTISBIO CO. LTD. Recent Developments
• 11.16 Tonghua Dongbao
  • 11.16.1 Tonghua Dongbao Company Information
  • 11.16.2 Tonghua Dongbao Overview
  • 11.16.3 Tonghua Dongbao Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.16.4 Tonghua Dongbao Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Tonghua Dongbao Recent Developments
• 11.17 Haichuang Pharmaceutical
  • 11.17.1 Haichuang Pharmaceutical Company Information
  • 11.17.2 Haichuang Pharmaceutical Overview
  • 11.17.3 Haichuang Pharmaceutical Gout Medications Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.17.4 Haichuang Pharmaceutical Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 Haichuang Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Gout Medications Industry Chain Analysis
• 12.2 Gout Medications Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Gout Medications Production Mode & Process
• 12.4 Gout Medications Sales and Marketing
  • 12.4.1 Gout Medications Sales Channels
  • 12.4.2 Gout Medications Distributors
• 12.5 Gout Medications Customers

13 Gout Medications Market Dynamics

• 13.1 Gout Medications Industry Trends
• 13.2 Gout Medications Market Drivers
• 13.3 Gout Medications Market Challenges
• 13.4 Gout Medications Market Restraints

14 Key Findings in the Global Gout Medications Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Gout Medications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Gout Relief Drugs

Table 3. Major Manufacturers of Gout Treatment Drugs

Table 4. Global Gout Medications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Gout Medications Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Gout Medications Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Gout Medications Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Gout Medications Revenue Market Share by Region (2019-2024)

Table 9. Global Gout Medications Revenue Market Share by Region (2025-2030)

Table 10. Global Gout Medications Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Gout Medications Sales by Region (2019-2024) & (K Units)

Table 12. Global Gout Medications Sales by Region (2025-2030) & (K Units)

Table 13. Global Gout Medications Sales Market Share by Region (2019-2024)

Table 14. Global Gout Medications Sales Market Share by Region (2025-2030)

Table 15. Global Gout Medications Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Gout Medications Sales Share by Manufacturers (2019-2024)

Table 17. Global Gout Medications Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Gout Medications Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Gout Medications, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Gout Medications Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Gout Medications Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Gout Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Medications as of 2023)

Table 23. Global Key Manufacturers of Gout Medications, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Gout Medications, Product Offered and Application

Table 25. Global Key Manufacturers of Gout Medications, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Gout Medications Sales by Type (2019-2024) & (K Units)

Table 28. Global Gout Medications Sales by Type (2025-2030) & (K Units)

Table 29. Global Gout Medications Sales Share by Type (2019-2024)

Table 30. Global Gout Medications Sales Share by Type (2025-2030)

Table 31. Global Gout Medications Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Gout Medications Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Gout Medications Revenue Share by Type (2019-2024)

Table 34. Global Gout Medications Revenue Share by Type (2025-2030)

Table 35. Gout Medications Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Gout Medications Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Gout Medications Sales by Application (2019-2024) & (K Units)

Table 38. Global Gout Medications Sales by Application (2025-2030) & (K Units)

Table 39. Global Gout Medications Sales Share by Application (2019-2024)

Table 40. Global Gout Medications Sales Share by Application (2025-2030)

Table 41. Global Gout Medications Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Gout Medications Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Gout Medications Revenue Share by Application (2019-2024)

Table 44. Global Gout Medications Revenue Share by Application (2025-2030)

Table 45. Gout Medications Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Gout Medications Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Gout Medications Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Gout Medications Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Gout Medications Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Gout Medications Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Gout Medications Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Gout Medications Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Gout Medications Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Gout Medications Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Gout Medications Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Gout Medications Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Gout Medications Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Gout Medications Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Gout Medications Sales by Country (2025-2030) & (K Units)

Table 60. Europe Gout Medications Sales by Type (2019-2024) & (K Units)

Table 61. Europe Gout Medications Sales by Type (2025-2030) & (K Units)

Table 62. Europe Gout Medications Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Gout Medications Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Gout Medications Sales by Application (2019-2024) & (K Units)

Table 65. Europe Gout Medications Sales by Application (2025-2030) & (K Units)

Table 66. Europe Gout Medications Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Gout Medications Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Gout Medications Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Gout Medications Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Gout Medications Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Gout Medications Sales by Country (2019-2024) & (K Units)

Table 72. Europe Gout Medications Sales by Country (2025-2030) & (K Units)

Table 73. China Gout Medications Sales by Type (2019-2024) & (K Units)

Table 74. China Gout Medications Sales by Type (2025-2030) & (K Units)

Table 75. China Gout Medications Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Gout Medications Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Gout Medications Sales by Application (2019-2024) & (K Units)

Table 78. China Gout Medications Sales by Application (2025-2030) & (K Units)

Table 79. China Gout Medications Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Gout Medications Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Gout Medications Sales by Type (2019-2024) & (K Units)

Table 82. Asia Gout Medications Sales by Type (2025-2030) & (K Units)

Table 83. Asia Gout Medications Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Gout Medications Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Gout Medications Sales by Application (2019-2024) & (K Units)

Table 86. Asia Gout Medications Sales by Application (2025-2030) & (K Units)

Table 87. Asia Gout Medications Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Gout Medications Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Gout Medications Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Gout Medications Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Gout Medications Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Gout Medications Sales by Region (2019-2024) & (K Units)

Table 93. Asia Gout Medications Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Gout Medications Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Gout Medications Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Gout Medications Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Gout Medications Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Gout Medications Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Gout Medications Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Gout Medications Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Gout Medications Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Gout Medications Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Gout Medications Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Gout Medications Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Gout Medications Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Gout Medications Sales by Country (2025-2030) & (K Units)

Table 107. AstraZeneca Company Information

Table 108. AstraZeneca Description and Major Businesses

Table 109. AstraZeneca Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. AstraZeneca Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. AstraZeneca Recent Developments

Table 112. Merck Company Information

Table 113. Merck Description and Major Businesses

Table 114. Merck Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Merck Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Merck Recent Developments

Table 117. Hikma Pharmaceuticals plc Company Information

Table 118. Hikma Pharmaceuticals plc Description and Major Businesses

Table 119. Hikma Pharmaceuticals plc Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Hikma Pharmaceuticals plc Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Hikma Pharmaceuticals plc Recent Developments

Table 122. Takeda Pharmaceutical Company Limited Company Information

Table 123. Takeda Pharmaceutical Company Limited Description and Major Businesses

Table 124. Takeda Pharmaceutical Company Limited Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Takeda Pharmaceutical Company Limited Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Takeda Pharmaceutical Company Limited Recent Developments

Table 127. Sebelalreland Company Information

Table 128. Sebelalreland Description and Major Businesses

Table 129. Sebelalreland Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Sebelalreland Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Sebelalreland Recent Developments

Table 132. Teijin Pharma Company Information

Table 133. Teijin Pharma Description and Major Businesses

Table 134. Teijin Pharma Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Teijin Pharma Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Teijin Pharma Recent Developments

Table 137. Sanofi Company Information

Table 138. Sanofi Description and Major Businesses

Table 139. Sanofi Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Sanofi Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Sanofi Recent Developments

Table 142. FUJI YAKUHIN Company Information

Table 143. FUJI YAKUHIN Description and Major Businesses

Table 144. FUJI YAKUHIN Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. FUJI YAKUHIN Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. FUJI YAKUHIN Recent Developments

Table 147. Savient Pharmaceuticals, Inc. Company Information

Table 148. Savient Pharmaceuticals, Inc. Description and Major Businesses

Table 149. Savient Pharmaceuticals, Inc. Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. Savient Pharmaceuticals, Inc. Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Savient Pharmaceuticals, Inc. Recent Developments

Table 152. lroko Pharmaceuticals Company Information

Table 153. lroko Pharmaceuticals Description and Major Businesses

Table 154. lroko Pharmaceuticals Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. lroko Pharmaceuticals Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. lroko Pharmaceuticals Recent Developments

Table 157. Novartis Company Information

Table 158. Novartis Description and Major Businesses

Table 159. Novartis Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. Novartis Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Novartis Recent Developments

Table 162. Astellas Pharma Hong Kong Co., Ltd Company Information

Table 163. Astellas Pharma Hong Kong Co., Ltd Description and Major Businesses

Table 164. Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 165. Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Astellas Pharma Hong Kong Co., Ltd Recent Developments

Table 167. Hengrui Medicine Company Information

Table 168. Hengrui Medicine Description and Major Businesses

Table 169. Hengrui Medicine Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 170. Hengrui Medicine Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Hengrui Medicine Recent Developments

Table 172. ApicHope Company Information

Table 173. ApicHope Description and Major Businesses

Table 174. ApicHope Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 175. ApicHope Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 176. ApicHope Recent Developments

Table 177. INVENTISBIO CO. LTD. Company Information

Table 178. INVENTISBIO CO. LTD. Description and Major Businesses

Table 179. INVENTISBIO CO. LTD. Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 180. INVENTISBIO CO. LTD. Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 181. INVENTISBIO CO. LTD. Recent Developments

Table 182. Tonghua Dongbao Company Information

Table 183. Tonghua Dongbao Description and Major Businesses

Table 184. Tonghua Dongbao Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 185. Tonghua Dongbao Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 186. Tonghua Dongbao Recent Developments

Table 187. Haichuang Pharmaceutical Company Information

Table 188. Haichuang Pharmaceutical Description and Major Businesses

Table 189. Haichuang Pharmaceutical Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 190. Haichuang Pharmaceutical Gout Medications Product Model Numbers, Pictures, Descriptions and Specifications

Table 191. Haichuang Pharmaceutical Recent Developments

Table 192. Key Raw Materials Lists

Table 193. Raw Materials Key Suppliers Lists

Table 194. Gout Medications Distributors List

Table 195. Gout Medications Customers List

Table 196. Gout Medications Market Trends

Table 197. Gout Medications Market Drivers

Table 198. Gout Medications Market Challenges

Table 199. Gout Medications Market Restraints

Table 200. Research Programs/Design for This Report

Table 201. Key Data Information from Secondary Sources

Table 202. Key Data Information from Primary Sources

List of Figures

Figure 1. Gout Medications Product Picture

Figure 2. Global Gout Medications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Gout Medications Market Share by Type: 2023 & 2030

Figure 4. Gout Relief Drugs Product Picture

Figure 5. Gout Treatment Drugs Product Picture

Figure 6. Global Gout Medications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Gout Medications Market Share by Application: 2023 & 2030

Figure 8. Primary Gout

Figure 9. Secondary Gout

Figure 10. Gout Medications Report Years Considered

Figure 11. Global Gout Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 13. Global Gout Medications Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 14. Global Gout Medications Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Gout Medications Revenue Market Share by Region (2019-2030)

Figure 16. Global Gout Medications Sales (2019-2030) & (K Units)

Figure 17. Global Gout Medications Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 18. Global Gout Medications Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Gout Medications Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Gout Medications Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Gout Medications Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Gout Medications Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Gout Medications Sales YoY (2019-2030) & (K Units)

Figure 24. China Gout Medications Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Gout Medications Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Gout Medications Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Gout Medications Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Gout Medications Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Global Gout Medications Sales Share by Manufacturers (2023)

Figure 30. The Gout Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. Global Gout Medications Revenue Share by Manufacturers (2023)

Figure 32. The Top 5 and 10 Largest Manufacturers of Gout Medications in the World: Market Share by Gout Medications Revenue in 2023

Figure 33. Global Gout Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Gout Medications Sales Market Share by Type (2019-2030)

Figure 35. Global Gout Medications Revenue Market Share by Type (2019-2030)

Figure 36. Global Gout Medications Sales Market Share by Application (2019-2030)

Figure 37. Global Gout Medications Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Gout Medications Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Gout Medications Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Gout Medications Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Gout Medications Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Gout Medications Revenue Share by Country (2019-2030)

Figure 43. US & Canada Gout Medications Sales Share by Country (2019-2030)

Figure 44. US Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Gout Medications Sales Market Share by Type (2019-2030)

Figure 47. Europe Gout Medications Revenue Market Share by Type (2019-2030)

Figure 48. Europe Gout Medications Sales Market Share by Application (2019-2030)

Figure 49. Europe Gout Medications Revenue Market Share by Application (2019-2030)

Figure 50. Europe Gout Medications Revenue Share by Country (2019-2030)

Figure 51. Europe Gout Medications Sales Share by Country (2019-2030)

Figure 52. Germany Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 53. France Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 57. China Gout Medications Sales Market Share by Type (2019-2030)

Figure 58. China Gout Medications Revenue Market Share by Type (2019-2030)

Figure 59. China Gout Medications Sales Market Share by Application (2019-2030)

Figure 60. China Gout Medications Revenue Market Share by Application (2019-2030)

Figure 61. Asia Gout Medications Sales Market Share by Type (2019-2030)

Figure 62. Asia Gout Medications Revenue Market Share by Type (2019-2030)

Figure 63. Asia Gout Medications Sales Market Share by Application (2019-2030)

Figure 64. Asia Gout Medications Revenue Market Share by Application (2019-2030)

Figure 65. Asia Gout Medications Revenue Share by Region (2019-2030)

Figure 66. Asia Gout Medications Sales Share by Region (2019-2030)

Figure 67. Japan Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 71. India Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 72. Australia Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 73. Middle East, Africa and Latin America Gout Medications Sales Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Gout Medications Revenue Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Gout Medications Sales Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Gout Medications Revenue Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Gout Medications Revenue Share by Country (2019-2030)

Figure 78. Middle East, Africa and Latin America Gout Medications Sales Share by Country (2019-2030)

Figure 79. Brazil Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 80. Mexico Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 81. Turkey Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 82. Israel Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 83. GCC Countries Gout Medications Revenue (2019-2030) & (US$ Million)

Figure 84. Gout Medications Value Chain

Figure 85. Gout Medications Production Process

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed